Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
3 Stories To Watch At The Year’s Biggest Cancer Conference
Investors.com
Mon, 05/30/16 - 06:34 pm
ASCO 2016
Pfizer
Eli Lilly
breast cancer
Ibrance
abemaciclib
AbbVie
non-small cell lung cancer
Rova-T
Keytruda
Bristol-Myers Squibb
Merck
Opdivo
Bet You Can't Guess Which of These 10 Big Pharma Names Has the Largest Late-Stage Pipeline
Motley Fool
Mon, 05/30/16 - 10:13 am
JNJ
Pfizer
Novartis
Merck
Bristol-Myers Squibb
GSK
Sanofi
AbbVie
Eli Lilly
AstraZeneca
How Do Allergan’s Valuations Compare to Its Peers’?
Yahoo/Market Realist
Sat, 05/28/16 - 10:49 am
Allergan
AbbVie
Pfizer
Merck
Biogen, AbbVie once-monthly MS injection wins U.S. approval
Yahoo/Reuters
Fri, 05/27/16 - 11:03 pm
Biogen
AbbVie
MS
multiple sclerosis
FDA
Zinbryta
Pharma is gentrifying biotech’s hottest neighborhood, but some are mindful of displacing startups
Stat
Thu, 05/26/16 - 10:56 pm
Kendall Square
biotech
Eli Lilly
Pfizer
AbbVie
Cambridge MA
AbbVie’s Newly Licensed Drug Scores Against Crohn’s Disease
Investors.com
Tue, 05/24/16 - 11:54 pm
AbbVie
Crohn's Disease
risankizumab
Boehringer Ingelheim
4 Top Stocks in the Growing Medical Marijuana Industry
TheStreet.com
Wed, 05/18/16 - 04:23 pm
Medical Marijuana
AbbVie
Cara Therapeutics
GW Pharma
INSYS Therapeutics
How Biotech Companies Expecting M&A Deals Can Offer High Returns
Investopedia
Wed, 05/18/16 - 11:06 am
M&A
biotech
AbbVie
Abbott Labs
Stemcentrx
St. Jude Medical
Bristol-Myers, AbbVie open two new facilities this week that will employ 250
Bizjournals.com
Tue, 05/17/16 - 05:49 pm
Bristol-Myers Squibb
AbbVie
drug manufacturing
AbbVie Slides as U.S. Agency Questions Humira Patent
Bloomberg
Tue, 05/17/16 - 12:07 pm
AbbVie
Humira
patents
Coherus Biosciences
rheumatoid arthritis
Merck May Need More Than Just Bolt-On Acquisitions
Seeking Alpha
Thu, 05/12/16 - 09:45 am
Merck
AbbVie
Bristol-Myers Squibb
Pfizer
Gilead Sciences
M&A
With competition lurking, Eli Lilly's baricitinib must show unparalled efficacy
Medical Marketing and Media
Wed, 05/11/16 - 10:52 am
Eli Lilly
baricitinib
JAK inhibitors
Pfizer
Xeljanz
Enbrel
AbbVie
Humira
JNJ
Remicade
AbbVie adds $250M in milestones to Galapagos cystic fibrosis deal
Fierce Biotech
Thu, 05/5/16 - 02:08 pm
AbbVie
Galapagos
cystic fibrosis
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Fierce Pharma
Wed, 05/4/16 - 09:48 am
Amgen
Kyprolis
JNJ
Bristol-Myers Squibb
Multiple Myeloma
Darzalex
Empliciti
AbbVie
Takeda
Ninlaro
Multiple sclerosis drug from Biogen, AbbVie clears regulatory hurdle in EU
BioPharma Dive
Mon, 05/2/16 - 09:36 am
Biogen
AbbVie
MS
multiple sclerosis
Europe
Zinbryta
Biogen, AbbVie multiple sclerosis drug wins EU green light
Yahoo/Reuters
Fri, 04/29/16 - 10:59 am
Biogen
AbbVie
MS
multiple sclerosis
Zinbryta
Europe
AbbVie agrees to buy Peter Thiel-backed biotech Stemcentrx
Marketwatch
Thu, 04/28/16 - 09:42 am
AbbVie
Stemcentrx
M&A
This Big Pharma Stock Is Set to Profit From an Immunology Bonanza
TheStreet.com
Mon, 04/25/16 - 06:40 pm
AbbVie
cancer immunotherapy
AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAKwithout Ribavirin in Genotype 1b Chronic Hepatitis C Patients with Compensated Cirrhosis
Yahoo
Mon, 04/25/16 - 06:39 pm
AbbVie
FDA
Viekira Pak
hepatitis C
AbbVie Inc (ABBV) Q1 Earnings: Here’s What to Expect
Bidness, ETC
Mon, 04/25/16 - 09:27 am
AbbVie
earnings
Pages
« first
‹ previous
…
47
48
49
50
51
52
53
54
55
…
next ›
last »